| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Targovax ASA (OL: TRVX)
TRVX Technical Analysis
5
| As on 9th Jun 2023 TRVX SHARE Price closed @ 0.56 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.50 & Strong Sell for SHORT-TERM with Stoploss of 1.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TRVXSHARE Price
| Open | 0.53 | Change | Price | % |
| High | 0.58 | 1 Day | 0.03 | 5.66 |
| Low | 0.50 | 1 Week | -0.03 | -5.08 |
| Close | 0.56 | 1 Month | -0.07 | -11.11 |
| Volume | 688055 | 1 Year | -1.33 | -70.37 |
| 52 Week High 2.72 | 52 Week Low 0.49 | ||||
OL Norway Most Active Stocks
| PGS | 6.97 | -3.19% |
| NANOV | 2.23 | -20.64% |
| AOW | 2.00 | -5.21% |
| IDEX | 0.71 | 0.00% |
| ENSU | 0.12 | 0.00% |
| SCANA | 1.99 | 2.05% |
| EQNR | 313.65 | 1.98% |
| ACH | 3.90 | 2.36% |
| ARCH | 0.91 | -1.09% |
| NAS | 12.12 | 0.83% |
OL Norway Top Gainers Stocks
OL Norway Top Losers Stocks
| TRVX Daily Charts |
TRVX Intraday Charts |
Whats New @ Bazaartrend |
TRVX Free Analysis |
|
|
TRVX Important Levels Intraday
| RESISTANCE | 0.71 |
| RESISTANCE | 0.66 |
| RESISTANCE | 0.63 |
| RESISTANCE | 0.60 |
| SUPPORT | 0.52 |
| SUPPORT | 0.49 |
| SUPPORT | 0.46 |
| SUPPORT | 0.41 |
TRVX Forecast April 2024
| 4th UP Forecast | 1.79 |
| 3rd UP Forecast | 1.4 |
| 2nd UP Forecast | 1.15 |
| 1st UP Forecast | 0.91 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.28 |
| 4th DOWN Forecast | -0.67 |
TRVX Weekly Forecast
| 4th UP Forecast | 3.47 |
| 3rd UP Forecast | 2.54 |
| 2nd UP Forecast | 1.96 |
| 1st UP Forecast | 1.38 |
| 1st DOWN Forecast | -0.26 |
| 2nd DOWN Forecast | -0.84 |
| 3rd DOWN Forecast | -1.42 |
| 4th DOWN Forecast | -2.35 |
TRVX Forecast2024
| 4th UP Forecast | 6.01 |
| 3rd UP Forecast | 4.26 |
| 2nd UP Forecast | 3.18 |
| 1st UP Forecast | 2.1 |
| 1st DOWN Forecast | -0.98 |
| 2nd DOWN Forecast | -2.06 |
| 3rd DOWN Forecast | -3.14 |
| 4th DOWN Forecast | -4.89 |
Targovax ASA ( OL Norway Symbol : TRVX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TRVX Business Profile
Targovax ASA, a clinical stage immuno-oncology company, engages in the development of immune activators to target hard-to-treat solid tumors. Its lead product candidate is ONCOS-102, which is in Phase I/II clinical studies for the treatment of mesothelioma, melanoma, and colorectal cancer. The company is also developing neoantigen cancer vaccines targeting tumors with oncogenic RAS?mutations. In addition, it is developing ONCOS-211 for next generation ONCOS viruses. The company has collaboration agreements with Cancer Research Institute and Ludwig Cancer Research to develop ONCOS-102 for colorectal cancer with peritoneal carcinomatosis; Valo Therapeutics to develop mutant RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology; and Papyrus Therapeutics to develop novel ONCOS viruses with Receptor Tyrosine Kinase inhibitor functionality. Targovax ASA was incorporated in 2010 and is based in Lysaker, Norway. Address: Vollsveien 19, Lysaker, Norway, 1366
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service